202 related articles for article (PubMed ID: 34472337)
1. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent
Fallica AN; Sorrenti V; D'Amico AG; Salerno L; Romeo G; Intagliata S; Consoli V; Floresta G; Rescifina A; D'Agata V; Vanella L; Pittalà V
J Med Chem; 2021 Sep; 64(18):13373-13393. PubMed ID: 34472337
[TBL] [Abstract][Full Text] [Related]
2. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.
Mucha O; Podkalicka P; Mikulski M; Barwacz S; Andrysiak K; Biela A; Mieczkowski M; Kachamakova-Trojanowska N; Ryszawy D; Białas A; Szelążek B; Grudnik P; Majewska E; Michalik K; Jakubiec K; Bień M; Witkowska N; Gluza K; Ekonomiuk D; Sitarz K; Gałęzowski M; Brzózka K; Dubin G; Józkowicz A; Dulak J; Łoboda A
Arch Biochem Biophys; 2019 Aug; 671():130-142. PubMed ID: 31276659
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
Salerno L; Pittalà V; Romeo G; Modica MN; Siracusa MA; Di Giacomo C; Acquaviva R; Barbagallo I; Tibullo D; Sorrenti V
Bioorg Med Chem; 2013 Sep; 21(17):5145-53. PubMed ID: 23867390
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
[TBL] [Abstract][Full Text] [Related]
6. Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region.
Floresta G; Fallica AN; Romeo G; Sorrenti V; Salerno L; Rescifina A; Pittalà V
Bioorg Chem; 2020 Nov; 104():104310. PubMed ID: 33010625
[TBL] [Abstract][Full Text] [Related]
7. Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.
Romeo G; Ciaffaglione V; Amata E; Dichiara M; Calabrese L; Vanella L; Sorrenti V; Grosso S; D'Amico AG; D'Agata V; Intagliata S; Salerno L
Molecules; 2021 Jun; 26(13):. PubMed ID: 34202711
[TBL] [Abstract][Full Text] [Related]
8. New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.
Ciaffaglione V; Intagliata S; Pittalà V; Marrazzo A; Sorrenti V; Vanella L; Rescifina A; Floresta G; Sultan A; Greish K; Salerno L
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168943
[TBL] [Abstract][Full Text] [Related]
9. Immune Modulation by Inhibitors of the HO System.
Fernández-Fierro A; Funes SC; Rios M; Covián C; González J; Kalergis AM
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396647
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationships of 1,2-Disubstituted Benzimidazoles: Selective Inhibition of Heme Oxygenase-2 Activity.
Kong X; Vukomanovic D; Nakatsu K; Szarek WA
ChemMedChem; 2015 Aug; 10(8):1435-41. PubMed ID: 26083133
[TBL] [Abstract][Full Text] [Related]
11. Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers.
Floresta G; Carotti A; Ianni F; Sorrenti V; Intagliata S; Rescifina A; Salerno L; Di Michele A; Sardella R; Pittalà V
Bioorg Chem; 2020 Jun; 99():103777. PubMed ID: 32222619
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor.
Marinissen MJ; Tanos T; Bolós M; de Sagarra MR; Coso OA; Cuadrado A
J Biol Chem; 2006 Apr; 281(16):11332-46. PubMed ID: 16476737
[TBL] [Abstract][Full Text] [Related]
13. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
Salerno L; Floresta G; Ciaffaglione V; Gentile D; Margani F; Turnaturi R; Rescifina A; Pittalà V
Eur J Med Chem; 2019 Apr; 167():439-453. PubMed ID: 30784878
[TBL] [Abstract][Full Text] [Related]
14. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors.
Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
J Med Chem; 2006 Jul; 49(14):4437-41. PubMed ID: 16821802
[TBL] [Abstract][Full Text] [Related]
15. Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation.
Greish KF; Salerno L; Al Zahrani R; Amata E; Modica MN; Romeo G; Marrazzo A; Prezzavento O; Sorrenti V; Rescifina A; Floresta G; Intagliata S; Pittalà V
Molecules; 2018 May; 23(5):. PubMed ID: 29783634
[TBL] [Abstract][Full Text] [Related]
16. Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitors.
Vukomanovic D; McLaughlin B; Rahman MN; Vlahakis JZ; Roman G; Dercho RA; Kinobe RT; Hum M; Brien JF; Jia Z; Szarek WA; Nakatsu K
Can J Physiol Pharmacol; 2010 Apr; 88(4):480-6. PubMed ID: 20555417
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms.
Kinobe RT; Vlahakis JZ; Vreman HJ; Stevenson DK; Brien JF; Szarek WA; Nakatsu K
Br J Pharmacol; 2006 Feb; 147(3):307-15. PubMed ID: 16331285
[TBL] [Abstract][Full Text] [Related]
18. Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis.
Floresta G; Pittalà V; Sorrenti V; Romeo G; Salerno L; Rescifina A
Bioorg Chem; 2018 Dec; 81():334-339. PubMed ID: 30189413
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors.
Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
Bioorg Med Chem Lett; 2005 Mar; 15(5):1457-61. PubMed ID: 15713406
[TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells.
Dulak J; Józkowicz A; Foresti R; Kasza A; Frick M; Huk I; Green CJ; Pachinger O; Weidinger F; Motterlini R
Antioxid Redox Signal; 2002 Apr; 4(2):229-40. PubMed ID: 12006174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
